Facebook
Twitter
LinkedIn
Forward
Parkinsons Disease Psychosis: Managing Complex Patients With Behavioral Manifestations (CE Symposium)
To claim your credit for the symposium, please click Register/Take Course.
Activity Description and Purpose
Parkinsons disease psychosis (PDP), particularly with behavioral manifestations, is a complex debilitating condition that needs early identification and treatment with nonpharmacologic and pharmacologic interventions. Advanced practice nurses are at the forefront of managing and coordinating care of patients with PDP, especially in the long-term care setting. The desired results of this activity are for advanced practice nurses to become more adept at identifying PDP and develop person-centered nonpharmacologic and pharmacologic management plans for older adults with PDP who exhibit behavioral disturbances.
Target Audience
This educational activity is intended for advanced practice nurses and other clinicians caring for patients with Parkinsons disease psychosis.
Learning Objectives
After completing this activity, participants will be better able to:
- Identify the signs and symptoms of Parkinsons disease psychosis
- Design person-centered nonpharmacologic management plans for older adults with Parkinsons disease psychosis who exhibit behavioral disturbances
- Develop person-centered pharmacologic management plans for older adults with Parkinsons disease psychosis
Faculty
 | Fay Hardison Bembry, MSN, FNP-BC, PMHNP-BC (Chair) Psychiatric Mental Health Nurse Practitioner Team Health Behavioral Health Services Johnson City, Tennessee |
 | Susan Scanland, MSN, CRNP, GNP-BC, CDP CEO/Founder Dementia Connection LLC Gerontological Nurse Practitioner Clarks Summit, Pennsylvania |
Disclosure Policy
Amedco LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to Amedco policy. Amedco LLC is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Faculty
Fay Hardison Bembry, MSN, is on the speakers bureau for ACADIA Pharmaceuticals Inc, Otsuka America Pharmaceutical, Inc, and Teva Pharmaceutical USA, Inc.
Susan Scanland, MSN, is a consultant for ACADIA Pharmaceuticals Inc, BioXcel Therapeutics, H Lundbeck A/S, Otsuka America Pharmaceutical, Inc, and Teva Pharmaceutical USA, Inc; is an advisory board member of ACADIA Pharmaceuticals Inc, BioXcel Therapeutics, Eisai Co, Ltd, H Lundbeck A/S, Otsuka America Pharmaceutical, Inc, and Teva Pharmaceutical USA, Inc; and is on the speakers bureau for ACADIA Pharmaceuticals Inc, Eisai Co, Ltd, H Lundbeck A/S, Otsuka America Pharmaceutical, Inc, and Teva Pharmaceutical USA, Inc.
Peer Reviewer
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners, Managers, and Writers
Carrie Allen, PharmD, BCPP, BCPS, MedEdicus Content Manager for this activity, was previously employed by CVS within the past 2 years, but that relationship has ended.
Other MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. You must attend the entire symposium as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Interprofessional Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by MedEdicus LLC and Amedco LLC. Amedco LLC is jointly accredited by the ACCME, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Nursing Credit
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.
Disclosure of Commercial Support
This continuing education activity is supported through an educational grant from ACADIA Pharmaceuticals Inc.
Off-Label Discussion
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC, Amedco LLC, or ACADIA Pharmaceuticals Inc.
©2023 MedEdicus LLC. 303.1
Available Credit
- 1.00 ANCC